Notably, the inhibition of tumor growth and improved survival in C5aR−/− mice was abrogated by depleting CXCL9 (Figure 5E), suggesting that the enhanced antitumor function by C5aR deletion depends on CXCL9-mediated recruitment of CD8+ T cells. The gene discussed is C5AR1; the disease is neoplasm.